Sex Hormone Signaling Suppresses Ferroptosis via Phospholipid Remodeling

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Estrogen receptor-positive (ER+) breast cancer and androgen receptor-positive (AR+) prostate cancer are common malignancies.
• Ferroptosis is a regulated form of cell death implicated in cancer progression.
• Mechanisms by which these cancers evade cell death are critical areas of research.

Purpose of the Study:

• To investigate the role of MBOAT1 and MBOAT2 in ferroptosis regulation in ER+ breast and AR+ prostate cancers.
• To identify specific molecular pathways involved in ferroptosis suppression in these cancer types.

Main Methods:

• Utilized cell culture models of ER+ breast and AR+ prostate cancer.
• Employed gene silencing techniques (e.g., siRNA, shRNA) to inhibit MBOAT1 and MBOAT2.
• Assessed cell viability, ferroptosis markers (e.g., lipid peroxidation), and protein expression levels.

Main Results:

• ER+ breast cancer cells showed suppressed ferroptosis, which was linked to MBOAT1 activity.
• AR+ prostate cancer cells demonstrated reduced ferroptosis, associated with MBOAT2 expression.
• Inhibition of MBOAT1 or MBOAT2 partially restored ferroptosis in the respective cancer models.

Conclusions:

• MBOAT1 and MBOAT2 play distinct roles in suppressing ferroptosis in ER+ breast and AR+ prostate cancers, respectively.
• Targeting MBOAT1 or MBOAT2 may represent a novel therapeutic strategy to induce ferroptosis in these hormone-driven cancers.